Lung Diseases, Obstructive  >>  Veramyst (fluticasone furoate nasal spray)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Veramyst (fluticasone furoate nasal spray) / GSK
NCT01808339: To Investigate the Effects of Altering the Time of Day of Dosing (Morning or Evening) With Fluticasone Furoate 100 Micrograms Once Daily Administered Via a Dry Powder Inhaler in Subjects With Asthma

Completed
2
28
RoW
Fluticasone Furoate (FF), Placebo
GlaxoSmithKline
Asthma
03/14
03/14
NCT01563029: A Dose-ranging Study of Fluticasone Furoate (FF)

Completed
2
597
Japan, US, Europe, RoW
Fluticasone Furoate, Fluticasone Propionate, Placebo
GlaxoSmithKline
Asthma
09/14
09/14

Download Options